Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
This study is currently recruiting participants.
Verified January 2013 by GlaxoSmithKline
Study NCT01031069   Information provided by GlaxoSmithKline

First Received on December 10, 2009.   Last Updated on February 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Human Papillomavirus Infection
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Infections
Immunologic Deficiency Syndromes
Papillomavirus Infections
Warts
More general conditions related to this trial
DNA Virus Infections
Immune System Diseases
Lentivirus Infections
Neoplasms
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Viral
Slow Virus Diseases
Tumor Virus Infections
Virus Diseases
Interventions listed in this trial
GSK Biologicals' HPV vaccine 580299
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services